Novel Endpoints in MRD in Multiple Myeloma Novel Drugs Targeting BiTE Platform

Martina A. Sersch, MD, Executive Medical Director at Amgen Inc., shares Novel Endpoints in MRD in Multiple Myeloma Novel Drugs Targeting BiTE Platform at Annual Meeting 2018